There were multiple errors and an omission in the Funding Statement. The Funding Statement should read: "The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development  and is supported by participating universities and mental health care organizations , Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). This work was supported by the Top Institute Pharma, project number T5-203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."


In the Funding Statement, an organization was incorrectly as having provided funding for the article. The Funding Statement should read: "This work was supported by a Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant and Academic Project Support (APS) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."


There was an error in the Funding statement. The correct version of the statement is available below:This work was supported by the Society for Research on Cardiovascular Diseases, the Ministry of Culture, Health and Higher Education, and the National Fund for Research of Luxembourg. Profs. Ng and Squire and Dr. McCann received support from the NIHR Leicester Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There is an error in the Competing Interests statement. The Competing Interests statement should read: "AMD is currently a Professor of Pathology, Urology and Oncology at the Johns Hopkins University School of Medicine  and was also employed as such during the conduct of this study. During part of the writing of this manuscript AMD was employed at Predictive Biosciences, Inc. , as well as part-time adjunct Professor of Pathology, Oncology, and Urology at the Johns Hopkins University School of Medicine . No funding or other support was provided by Predictive Biosciences, Inc., for any of the work in this manuscript. The terms of the relationship between AMD and Predictive Biosciences, Inc., were managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials."


There was an error in the funding statement. The correct funding is:http://www.rcn.no) , the Cancer Foundation of Norway (http://www.kreftforeningen.no) (to KKA), and the NSF-Biochem 0919027 to EIS). The Raman instrument and laser equipment in Oslo was funded by a grant from the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by The PEOPLE Marie Curie Actions Intra–European Fellowship within the 7th European Community Framework Programme (PIEF–GA–2009–235237 to GZ), the Research Council of Norway (


The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The Funding statement is incorrect. The publisher apologizes for the error. The correct Funding statement is: This research was financially supported by the National Key Technologies R&D Program (2015BAD07B01), the National Natural Science Foundation of China (31270656,


There is an error in the funding statement. Please refer to the complete funding statement here:This research was supported by funds from the Cave Conservancy Foundation , Society of Systematic Biologists (Graduate Student Research Award), and the American Arachnological Society (Vincent Roth Fund for Systematics Research) awarded to S Derkarabetian. This research was also supported by an NSF grant awarded to M Hedin (DEB 1354558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: This project was funded in part with Federal funds from the National Institutes of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, under Contract No. 272200800007C, CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences, the Childhood Infections Research Program grant T32-AI095202-01, the Immunobiology of Blood and Vascular Systems training grant 5 T32 HL69765-12, and NIH grant GM064779. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.


ZYGX2014Z002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The Funding statement appears incorrectly in the published article. The correct Funding statement is: This work is partially supported by the National Natural Science Foundation of China (


The following information is missing from the Funding section: We acknowledge support by the Open Access Publication Fund of the University of Muenster.http://www.nf.mpg.de/). We also acknowledge support by the Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The complete, correct Funding statement is: The Max Planck Institute financed the fMRI study (


During typesetting, errors were introduced into the Funding section. The publisher apologizes for the error. The correct funding information is as follows: This work was supported by the Canadian Institutes of Health Research (RSN-109427) and the Saskatchewan Health Research Foundation to QL. ZL is a recipient of the University of Saskatchewan Vaccinology and Immunotherapeutics Ph.D. Student scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There is an error in the funding statement. Please refer to the correct funding statement below.This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement 5U2GPS001930-05 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author (s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. This work was supported through technical assistance from the Johns Hopkins Center for AIDS Research (1P30AI094189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The Global Center of Excellence (GCOE) for atomically controlled fabrication technology was established in 2008 by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), as a succession program of the 21st Century COE program for atomistic fabrication technology promoted from 2003 to 2007. The GCOE program is implemented by three departments, namely the Departments of Precision Science & Technology, Applied Physics, and Advanced Science and Biotechnology, and by the Research Center for Ultra-precision Science and Technology, all of which belong to the Graduate School of Engineering of Osaka University.The Fifth International Symposium on Atomically Controlled Fabrication Technology (ACFT-5) was organized by the GCOE program and the technical committee on ultraprecision machining of the Japan Society for Precision Engineering (JSPE), in cooperation with JSPE, the Japan Society of Applied Physics (JSAP), and the Physical Society of Japan (JPS).The aim of our GCOE project is to achieve the atomic level controllability in wide-area processing and environmental harmony, which are essential for next-generation manufacturing technologies with high functions. For this purpose, by collaborating with other organizations from different fields, we focus not only on the creation of new fabrication processes beyond the current limitations but also on the systematization of the fabrication processes as science.ACFT-5 highlights the recent achievements in the program. The topics covered here are ‘Impact of Quantum Beam Techniques with Advanced Optics’, ‘Surface Characterization and Bottom-up Technologies’, ‘Multi-Scale Surface Control Techniques’, ‘Advanced Processing and Materials Science for Device Applications’, and ‘Frontier in Carbon/Organic Nano-Scale Systems’. Finally, we would like to express our gratitude to all the contributors and committee members for their great effort in making the symposium successful and also to MEXT for its continuous support.


Prior to 1993, Nepal had a vertical health logistics system. Logistics was not a government priority. No logistics curricula had been developed, no staff had been trained, and no logistics information systems existed at any level. After the establishment of the Logistics Management Division in 1993, the lack of trained manpower in logistics was realized. With support of USAID funded projects (implemented by John Snow Incorporated through Family Planning Logistics Management (FPLM), Nepal Family Health Program, and DELIVER), logistics training was institutionalized within the National Health Training Centre of Ministry of Health and Population.With support from USAID, the National Health Training Centre and Logistics Management Division have worked to institutionalize logistics training. Trainers were trained and Regional Health Training centres have been conducting logistics training. Logistics training is included in National Health Training Centre’s annual work plan and approved by the National Planning commission. Logistics practices have been incorporated in the pre-service and in-service curricula and health logistics training has also been incorporated in the training management guideline of the National Health Training Centre.Logistics practices have been incorporated in the pre-service and in-service curricula. Technical assistance is being provided to establish or maintain training within a national training system and efforts are being made to build the capacity of government healthcare providers to manage training events. Ten standardized Health Logistics Training packages have been institutionalized into the National Health Training Centre system to train human resource needed for the logistics management of the country and computer based self-paced training (CD-ROM), has been developed.The Ministry of Health has recognized the importance of the not only logistics management but also the need for quality training. The Ministry of Health has initiated and is continuing provision of logistics training from its own financial resources ensuring sustainability of the program to some extent. From 1993 to 2013, a total of 27,734 government personnel have been trained in the health logistics trainings. Through the training important logistics interventions like Pull System of Health Commodities and web-based LMIS were successfully implemented in all 75 districts of the country.Frequent turnover of trained storekeepers and a lack of effective supervision after training remain concerns. The misconception among health workers that training will solve all performance problems hinders their ability to analyse gaps and subsequently address them; and overall governance and accountability of the Government are continued issues.


The following information is missing from the Funding section: National Clinical Key Subject Construction Project Fund of China funded this work. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


A second affiliation for the second author is not indicated. Yau-Huei Lai is also affiliated with Mackay Junior College of Medicine, Nursing, and Management, New Taipei City, Taiwan.The following information is missing from the Funding section: This work was partially funded by grants from National Science Council , Mackay Memorial Hospital  and Taiwan Foundation for geriatric emergency and critical care.


The following information is missing from the Funding section: This study was supported by Office of Naval Research Multidisciplinary University Research Initiative Grant N000141310672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There were additional funders for this article that were not included previously. Please refer to the correct funding statement below:This study was supported by a grant of the German medical acupuncture association (DÄgfA), China scholarship council and University Funds from the University Hospitals of Wuerzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


Fundamental and clinical experts from Japan, Korea and China, warmly gathered on the beautiful ice and snow city—Changchun, the capital of Jilin Province, China—during 23-26 January 2015, to present their research findings and participated in discussion relating to progress in biomaterials, stem cells and bone tissue engineering. The International Symposium on Recent Trend of Biomaterials and Stem Cells for Bone Tissue Engineering (BTE 2015) was hosted by the Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, and co-organized by the Department of Orthopaedics, China-Japan Union Hospital, Jilin University. It provided a new platform of academic and technological communication for fundamental researchers and orthopedic surgeons to express their diverse ideas and inspiring new cooperation.The field of tissue engineering has emerged as an important approach to the clinical therapy of damaged bone due to trauma, tumor resections or congenital anomalies . Besidesin vivo microenvironment is a promising strategy for tissue engineering and stem cell research [The participants focused on discussing the recent development of synthetic or natural bioscaffolds that can provide 3D architecture , 9, apprresearch . A serieresearch  or peptiresearch  have beeresearch , 19. TheWe made a concise report on this symposium, and some comments of the key speakers in the symposium were presented. We hope that their comments can arouse further interests of readers in discussing future strategies of bone tissue engineering and regenerative medicine. Moreover, we believed that the frequent appointment of researchers and orthopedic surgeons may inspire more and more ideas in the development of future clinical products of tissue engineering for orthopedic application.Chief Scientist and Director of the Nano Medical Engineering Laboratory at the RIKEN (from 2004). He received his Bachelor’s degree in polymer chemistry at Kyoto University and was awarded a doctorate in engineering from the same university in 1987. Since then he has held some posts as assistant and associate professor at Kyoto University, research fellow at the University of California, Irvine (1992-93), professor of the University of Tokushima, and Project Leader at the Kanagawa Academy of Science and Technology. Currently, he is also a visiting professor of some universities including Tokyo Institute of Technology, Tokyo Metropolitan University, Hokkaido University and Waseda University. He received the Award of Japanese Society of Biomaterials (2009) and Fellow, Biomaterial Science and Engineering (2012). His research focuses on biomaterial science, regenerative medical engineering, combinatorial bioengineering for the creation of functional polymers and soft nanotechnology.Comment: The surface properties are of prime importance in establishing the response to tissue from biomaterials. I have investigated the immobilization of growth factor proteins to provide a set of very powerful signals for cells. Immobilized growth factors stimulated cultured cells for a longer time and enhanced cell growth more than did soluble growth factors and also induced cellular differentiation. The effects of immobilized growth factors were visualized by their micropatterning on substrates. Recently, we extended the immobilization technology from chemical to biological one, which is protein engineering for synthesis of binding growth factors. We synthesized some types of growth factors carrying collagen binding sequence extracted from fibronectin. One of them was collagen binding-BMP, which was synthesized by silk worm, and directly injected or utilized with scaffold or visible-light-curable gelatin gel. We demonstrated that both of the direct injection and the bound implants significantly enhanced bone formation in animals. Another type of binding growth factors was also designed by combination with binding motif of underwater adhesive proteins composed of non-canonical amino acids such as phosphorylated serine from salivary statherin and 3,4-dihydroxyphenylalanine from mussel protein for binding to inorganic materials such as metals and ceramics. The technology uses not only usual protein engineering but also bioorthogonal approach. As a result osteogenetic differentiation was enhanced on the bound apatite. These new types of binding growth factor could contribute current treatment methods of various debilitating injuries and diseases and deliver on the therapeutic promise of bone tissue engineering.Professor in the Department of Polymer Science and Engineering at the School of Applied Chemical Engineering, Graduate School, Kyungpook National University. He is currently a director of Center for Intelligent Hybrid Nanomaterials and Processes supported by Brain Korea 21+ National Program. He obtained his Ph.D. degree in Polymer Chemistry at Kyoto University in 1987, and joined in the Department of Polymer Science and Engineering in 1988 as a professor. He has published more than 190 articles and his research is focused on surface modification, nanofiber scaffolds, functionalization of nanoparticles and liquid crystal sensors.Comment: During last one decade several advancements have been made in fabrication of scaffolds for tissue engineering using various techniques of fabrication and materials of different origin. The scaffolds for tissue engineering are ranging from nanofibers to nanoparticles and have been developed by tuning their morphology and architecture. Several breakthroughs have been reported and successful attempts have been made to overcome the drawbacks of the scaffolds fabricated by conventional and modern methods of scaffolds formation yet significant amount of research is required to control the vascularity of the scaffolds, which is a major challenge in the field of fabrication of scaffolds for bone tissue engineering. Although few attempts have been made by harvesting cells from donor/patient to vascularize the scaffolds before their implantation in the patient but area still need intensive research to develop scaffolds with proper vascularization. The worldwide research has achieved success in tissue engineering but matrix induced autologus condrocyte implantation has received little success in repair of cartilage. The bioactivity of scaffolds totally depends on surface topology, microstructure, chemistry and mechanical properties of scaffolds. Thus, controlling the cells behavior and remodeling is a critical step in development of next generation scaffolds for tissue engineering. The functionalized scaffolds loaded with certain amount of growth factor and therapeutics to stimulate cells proliferation and treatment of infection after surgical operations also strongly needed to achieve success in the area of tissue engineering and regeneration. The increasing interest to incorporate a drug delivery function in the scaffolds is emerged as a new field of scaffolds engineering. The drug loaded scaffolds are able to provide sufficient amount of drug at a specific place in comparison to systematic drug delivery systems. The scaffolds loaded with growth factors such as cytokines, hormones, morphogens and proteins need to be developed to enhance cells adhesion, proliferation and differentiation in tissue engineering. The mechanical behavior of scaffolds has important implication on tissue regeneration; stiff scaffolds mimic precalcified bone and elastic scaffolds mimic the elasticity of muscles, which cause MSC differentiation down to a myogenic pathway. Thus, scaffolds with optimized mechanical strength need to be fabricated for enhanced bone tissue engineering. The critical review of the literature reported during last one decade has clearly indicated that there is lot of scope to improve the properties and functionality of the scaffolds for bone tissue engineering using various biomaterials and their fabrication techniques.Principal Investigator and Unit Director of Tissue Regeneration Materials Unit, International Center for Materials Nanoarchitectonics, National Institute for Materials Science, Japan. He obtained his Ph.D. from Kyoto University in 1997 majoring in biomaterials and did postdoctoral research until 2000. He became researcher in 2000 and senior researcher in 2003 at Tissue Engineering Research Center, National Institute for Advanced Industrial Science and Technology, Japan. He moved to Biomaterials Center, National Institute for Materials Science as senior researcher in 2004 and was group leader from January, 2007 to March, 2011. He is concurrently Professor of Joint Doctoral Program in Materials Science and Engineering, Graduate School of Pure and Applied Science, University of Tsukuba, Japan. He is Guest Professor of Shanghai Institute of Ceramics, Chinese Academy of Sciences; Southeast University and Sichuan University, China. He is Associate Editor of Journal of Materials Chemistry B; Editor of Science China Chemistry and Editorial Board of Journal of Bioactive and Compatible Polymers and Tissue Engineering .Comment: Tissue engineering has attracted tremendous endeavors from various fields of material science, biomedical science, chemical engineering, stem cell biology, clinics, industry and etc. The disciplinary research to regenerate functional tissues and organs has reached enormous progress and achievements spanning form fundamental research to clinical applications and industrialization. As one of the tissue engineering, triad, scaffolds not only accommodate implanted cells but also control cell functions to guide functional tissue engineering. Design and creation of highly functional scaffolds have been challenged to mimic the in vivo dynamically remodeling cellular microenvironments. Scaffolds with controlled chemical compositions, nano- and micro-structures, mechanical property and some special functions have been developed form synthetic and naturally derived biomaterials and decellularized matrices. The scaffolds can provide biological and physiochemical cues to recruit stem cells, induce stem cells differentiation and promote regeneration of various tissues and organs. Development of new and highly functional scaffolds will further facilitate efficient regeneration of functional tissues and organs for clinical applications and industrialization.Professor of Chemical and Biological Engineering and a Chairman of Interdisciplinary Program of Bioengineering in Seoul National University, South Korea. He is an active researcher with 275 peer-reviewed publications, 14 book chapters and 17 patents. He has received William B. Walsh Award and Shinyang Award. He had served or now serves as an Associate Editor or an editorial board member of 10 journals including the Tissue Engineering, Journal of Tissue Engineering and Regenerative Medicine, Biotechnology and Bioprocess Engineering, Journal of Industrial and Engineering Chemistry and Tissue Engineering and Regenerative Medicine. He is the chair of Scientific Committee of Korean Tissue Engineering and Regenerative Medicine Society and an organizer of 15th International Biotechnology Symposium.Comment: Currently, a number of bone graft substitutes have been developed and are being utilized clinically, but there are rooms for improvement. Bone graft substitutes can promote bone regeneration by the interaction of three components: (i) bone-forming cells, (ii) a suitable biomaterial scaffold and (iii) biological stimulants. In the International Symposium on Recent Trend of Biomaterials and Stem Cells for Bone Tissue Engineering (BTE 2015), which was held in Changchun in China in January, 2015, new technologies on these three components for bone regeneration were presented. For large bone-defect, stem cells or progenitor cells need to be implanted since recruitment of bone-forming cells to the large bone-defect may be limited. For effective bone regeneration, implantation of osteogenically induced stem cells or progenitor cells results in better bone regeneration rather than implantation of undifferentiated cells. Thus, decent technologies for ex vivo osteogenic induction of stem cells would be necessary. Meanwhile, biomaterials can be designed in nano scale to present biological stimulants for effective bone regeneration. BMPs are currently used for bone regeneration in patients, but often cause adverse effects due to the high dosage. Drug delivery carrier determines the bone regeneration efficacy of BMPs. Efforts should be made to develop an appropriate delivery carrier which can deliver BMPs without the adverse effects.Professor of polymer chemistry in Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences (CAS) from June 1999. He graduated from the Chemistry Department of Jilin University. He got his Master degree from CIAC in 1988. He got his Ph.D. from Waseda University Japan on March 1997. He had postdoc experience in the University of Pennsylvania from 1997 to 1999. Now he is working in Key Laboratory of Polymer Ecomaterials of CAS in CIAC. He is one of the board members of Journal of Controlled Release, Biomacromolecules, Advanced Healthcare Materials, Acta Biomaterialia and Macromolecular Bioscience. He has published 490 papers.Comment: In the past 20 years, the regenerative medicine materials, especially the tissue engineering repair materials have made important progress. Tissue engineering is an interdisciplinary field, including materials chemistry and physics, biological engineering, biochemistry, biomechanics, cell biology, biotechnology, clinical medicine, etc. It is one of the important means to repair and rebuild the body’s tissues and organs and has been becoming more and more important. The novel therapy method will change the quality and the way of people’s life, and extend the life of human beings in the near future. Biodegradable polymer material (absorbed in vivo) is one of the very important elements in the process of tissue engineering therapy. As a result, the preparation of porous bioscaffolds with adjustable absorption time, good strength, pore structure and distribution under well control, and good biocompatibility, are the objective requirements for the future development of tissue engineering therapy. We hope that through the joint efforts of scientists, more and more products of tissue engineering devices will be widely used in clinic in the near future.The ‘Qiu-shi’ Distinguished Professor and dean for School of Basic Medical Science, Vice Dean College of Medicine in Zhejiang University, China. He received his Ph.D. degree in orthopedics from National University of Singapore in 2003. Since returned to China in 2005, Prof. Ouyang focuses on the research of tissue engineering and regenerative therapy of musculoskeletal system. His research has been granted support by National Natural Science Foundation of China (NSFC) for Distinguished Young Scholars, The State Key Program of National Natural Science Foundation of China, The National Key Basic Research Program, The National High Technology Research and Development Program of China (863 Program), etc. Currently, he has filed 10 national patents applications (six approved) and published more than 60 original research papers in the international peer review journals. More than 40 papers corresponded by Prof. Ouyang were published in the leading journals of regenerative medicine fields, such as Stem Cells, Advanced Functional Materials/Biomaterials, Annals of the Rheumatic Disease, Tissue Eng, Cell Transplantation. Moreover, he was authorized by State Food and Drug Administration (SFDA) and Ministry Of Health (MOH) to formulate the guidance for assessment of implants for cartilage repair and therapeutic transplantation of engineered tissues, respectively. Prof. Ouyang has established a standard approach for tissue engineered cartilage (TEC) transplantation and is the pioneer of clinical translation in China orthopedic regenerative medicine. Because of his outstanding achievements, Prof. Ouyang has gained great national and international reputation, he is currently the chair of China Orthopedic Regenerative Medicine and the vice chair of China Tissue Engineering and Regenerative Medicine Society. He is also the council member of several international academic societies such as Tissue Engineering and Regenerative Medicine International Society-Asia Pacific Meeting (TERMIS-AP).Comment: Decades of experience indicated that manufacture of mature tissues with tissue engineering approaches for transplantation is difficult to be achieved. The most feasible and effective way is to apply one or all of the appropriate cell source, biomaterials/scaffold, growth factors according to particular tissues and diseases at the early or middle stage of diseases, which can prevent the tissue/organ from failure and avoid organ transplantation.Professor of Department of Chemistry, Tongji University, China. He obtained Ph.D. at the Shanghai Institute of Ceramics (CAS) in 2005, after which he worked as a postdoc in Hong Kong University of Science and Technology, University of Tokyo, and RIKEN. In 2011, he was appointed as a professor at Tongji University. His research interests focus on the mild polymerized preparation of tough nanocomposite gel and the potential applications in tissue engineering and bio-imaging. His current group has published more than 20 Science Citation Index papers, including Advance Materials and Chemical Science.Comment: Hydrogels with synthetic or natural polymer are useful in cartilage tissue engineering due to their water-swollen networks and suitable microenvironment for tissue formation. Up to now, engineering cartilage tissue still remains a significant challenge due to the low mechanical strength and unsuitable component design. The in-situ hydrogelations via the mild enzyme-mediated radical polymerization can provide a tough artificial cartilage by the direct injection in the defect position.Professor in Shanghai Institute of Ceramics, Chinese Academy of Sciences . He completed his Ph.D. in 2006, and then he worked in the University of Sydney, Dresden University of Technology, Germany and Queensland University of Technology where he was awarded Vice-Chancellor Research Fellow, APDI Fellow and Alexander von Humboldt Fellow. In 2012, Dr. Wu has been recruited to work in SIC, CAS, as One-Hundred Talent Program of Chinese Academy of Sciences. Then he was awarded Recruitment Program of Global Young Experts of China  and Shanghai Pujiang Talent Program. Prof. Wu’s research focuses on bioactive inorganic materials for bone tissue engineering and drug delivery application. Up to now, Prof. Wu has published more than 110 SCI peer-review journal papers, including Adv Funct Mater, Biomaterials (14 Papers), Adv Mater Interface, Small, J Control Release, J Mater Chem (15 Papers), Acta Biomater (22 Papers), ACS Appl Mater& Interface, Bone, Tissue Eng. etc. The papers have been cited more than 2300 times, H Index 31. Prof. Wu has been awarded 11 patents, in which three of them have been transferred to company.Comment: Regeneration of large-size bone defects represents a significant challenge clinically, which requires the used scaffolds with the stimulation of osteogenesis and angiogenesis for stem cells. It is known that microenvironments of bioscaffolds play an important role to stimulate tissue regeneration. How to design and prepare bioscaffolds with favorable microenvironments for tissue regeneration is one of interesting topics in the fields of biomaterials and tissue engineering. To establish a beneficial microenvironment of biomaterials, it is of great importance to combine both nutrient elements and biomimetic structure of scaffolds to stimulate osteogenesis and angiogenesis of stem cells. Besides the microenvironment of bioscaffolds, macrophage plays an important role to induce immunomodulatory microenvironment for further influencing osteogenesis. Therefore, it is suggested that scaffolds and osteoimmunomudulation-induced microenvironments should be considered for bone tissue engineering.et al. Currently, he has published over 60 original research papers.Dr. Zou is the director of the Orthopedic Research Institute and consultant surgeon of Spine Division at the First Affiliated Hospital of Sun Yat-sen University (SYSU). He graduated from Jiangxi Medical School, receiving the doctoral degree in Medical School of Aarhus University, Denmark. In 2008, Xuenong has been recruited as professor of the First Affiliated Hospital as One-Hundred Talent Program of SYSU. He has been focused on the interaction between biomaterials and host, the effect of ECM-biomaterials on bone formation, epigenetic mechanisms of osteogenetic progress induced by different biomaterials. His research has been supported by The State Key Program of National Natural Science Foundation of China, The National Key Basic Research Program (‘973’ Program) and The Key Program of NSFC-Guangdong Joint Fund, Comment: There exist three sequential biological events after implantation of biomaterials—stress and homeostasis, immuno-inflammatory responses and bone formation or implantation failure. The clinical result of the implantation depends on the first two events, happening in the interaction between biomaterials and human body. Therefore, it’s very important to elucidate the roles and mechanisms of early biological events caused by implantation of biomaterials, as a guide for synthesizing and designing biomaterials.Professor of Department of Orthopedics in China-Japan Union Hospital, Jilin University, China. He graduated from the Norman Bethune Medical University in 1991. He got his Doctor degree from Jilin University in 2003. He had his visiting scholar experience in the University of New South Wales in Australia from 2008 to 2009. He has been engaged in orthopedic clinic for more than 20 years. His main research work is on spine surgery and bone tissue engineering and has published more than 60 papers. Now he is the member of the expert committee of Chinese national medical examination center, the member of the Chinese Medical Association Branch of minimally invasive Department of orthopedics and one of the China core members of Medtronic MMSG Association.Comment:At present, there are about 3 million patients with defect bone or injured bone needed to be treated each year in China. More and more biological materials are demanded in orthopedic clinical work. To meet substantial clinical demand, with the high speed promotion of biomedical materials science and engineering, a high-tech biomedical materials and its products industry has already formed. But the present products of biomaterials can’t really biomimic the autologous grafts and the surgeons usually wondered that which was the best choice for a case when they face to a wide variety of products. Some of them will worry about the dissatisfied or even failed treatment and then refuse to accept the new products. One possible reason to affect the bone healing quality of a product might be the selection of operation indication or operation method but not the product itself. Thus, it is important for both researchers and surgeons that their frequent communication and cooperation will be conducive to the development of new biomaterials and the rapid development of orthopedic clinical technology.


The National Plan of Prevention PNP 2014-2018) [4-2018 1 acknowleContinuous training for health professionals started as a national program in Italy in 2002; some years later (2007) administrative control had been transferred from the Ministry of Health to the National Agency for Health Services, Agenas. At distance training and online updating are now becoming very common, close to traditional kinds of events for training, always in respect of the Evidence Based Medicine (EBM).We can identify, in the continuous sanitarian training system, different roles and various kinds of providers. Relevant organisations include the National Committee for Training, in the Ministry of Health, the Warranty Committee, and the National Observatory about Quality of Training.Regarding research in the field of health, we can consider it as the architrave of the National Health Service; the Report on Health Status in Italy 2012-13  defines The National Committee for Sanitarian Research defines the program and initiatives, monitors and evaluates the results. Research institutes involved in Italy must accept different challenges, according with the Singapore Declaration , which dThe European Union invested 80M Euro in research with Horizon 2020, in the aim of destroying barriers and realising, all over the world, a common environment concerning knowledge, research and innovation.A recent piece of research related to the food habits in the age of complementary feeding is Nutrintake 6/36 [


The correct funding information is as follows: This work was supported by the Sall Family Foundation via the Pan American Health and Education Foundation (renamed PAHO Foundation) and EUROHEALTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: The publisher apologizes for these errors.


There are errors in the Funding section. The correct funding information is as follows: This work was supported by National Institute of Health Research Grants R01DE10742 and R01DE14183, and The Mary Kay Foundation Research Grant number 005–13 (to DKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The Funding Statement is missing funding information from the NIH. Please see the full Funding Statement here.This study was funded by the Burroughs Wellcome Fund Award for Investigators in Pathogenesis (EEH) and the NIH T32-AI007422 (HGB). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The following information is missing from the Funding section: This research was supported in part by Judy Polshek Goodman Alzheimer's Disease Research and Prevention Fund, and a pilot grant from Philips Imaging.The complete, correct funding information is as follows: This research was supported in part by the Spitz Brain Health Innovation Fund, the G.R. Lincoln Family Foundation, Judy Polshek Goodman Alzheimer's Disease Research and Prevention Fund, and a pilot grant from Philips Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The publisher apologizes for the error.


The following information is missing from the Funding section: This work was supported in collaboration with the National Science Foundation, Partnerships for International Research and Education (OISE-0530174).Vibrio spp., and E. coli.There is an error in the first sentence of the third paragraph in the Introduction. The correct sentence is: In a study of bacteriological assessment of ballast waters of six ships docked at Singapore harbors, Joachimsthal et al. (2004) used fluorescence in situ hybridization (FISH) coupled with flow cytometry to enumerate total bacteria, and fluorescent tags to differentiate between Enterobacteria, There is an error in the caption for Please see the complete, correct


There is a missing grant number in the funding statement for this article. Please refer to the correct funding statement below:Research at QHFSS was funded by an internal funds provided by Queensland Health and the US National Institutes of Health/NIGMS U01GM097661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The identification number of the project was incorrect. The article was supported by the project DEC-2011/03/N/NZ5/00248 funded by National Science Centre.The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


There is an error in the affiliation for authors Mosoka Fallah, Josephine Monger, and Kodjo Tehoungue. The correct affiliation is: the World Health Organization.


There is an error in the grant number in the Financial Disclosure (FD) statement for this article. Please refer to the correct FD statement below:This study was supported by grants 81071095, 81120108011, and 81361128010 (to XX) from the National Natural Science Foundation of China, Suzhou science and technology development program (SYS201232), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China, Jiangsu Province’s Key Provincial Talents Program (to XX), and the National Basic Research Program of China . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


RRM was omitted from a grant in the Funding section. The correct Funding information is: This work was supported by the National Institute for Health Research , funds for consumables and WellChild (RRM and AD), funds were given to purchase the encapsulator used in the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There is an error in the Funding section. The correct funding information is as follows: The work was supported in part by grants from the Australian Research Council, Cancer Council Queensland to J.N. and the Internal Grant Agency (IGA) of the Ministry of Health of the Czech Republic (IGA NT/14078-3), and the European Regional Development Fund  to JN. EAP was supported by the Douglas Francis Green PhD Scholarship provided by the Queensland Asbestos-Related Disease Society. LFD was supported by the Griffith University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: This research was supported by the Hi-tech Research and Development Program of China (Grant No. 2012AA10A408 and 2012AA092203), the National Natural Sciences Foundation of China (Grant No. 31072245 and 31372567), the special foundation under the Construction Programme for ‘Taishan Scholarship’ of Shandong Province of China, and Special Scientific Research Funds for Central Non-profit Institute, Yellow Sea Fisheries Research Institute (20603022013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: Research was supported by the Czech Science Foundation (206–08–0640), the Ministry of Education, Youth and Sport of the Czech Republic (SVV260 087/2014), and the National Science Foundation (DEB0746560). Mouse pellets and genotyping of allopatric mice were reimbursed from the Czech Science Foundation (P506–11–1792). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.


Information is missing from the Funding section. The correct funding information is as follows: This work was supported by grants from the National Institutes of Health to CIG , JGF (PR-LSAMP and RISE Award 2R25GM61151), MHP and MM (R25GM061838). This publication was made possible by Grant P20 RR 016174 from the National Center for Research Resources, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


To the Editor: After not finding any additional cases of Middle East respiratory syndrome (MERS) for several weeks in South Korea, in July 2015, the South Korean government and the World Health Organization (WHO) discussed the appropriate time to declare the end of the outbreak in July 2015 . All possible contact with diagnosed case-patients in the late phase of the MERS outbreak in South Korea were traced (Epidemiologic data, probabilistic model, and supplementary discussion.


In Europe, colorectal cancer (CRC) is the second most common cancer, and the second most common cause of death from cancer . The vasGuidelines for staging of CRC have been developed by the European Society of Medical Oncology (ESMO) , which r


William B. Karesh is not included in the author byline. He should be listed as the tenth author and affiliated with Wildlife Health and Health Policy Program, Wildlife Conservation Society, Bronx, New York, United States of America. The contributions of this author are as follows: Collected and provided fecal samples analyzed in the manuscript.


After publication of this work , it has “The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA, NIHR, NHS or the Department of Health.”The full acknowledgements section can be found below:This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 10/104/06). Thank you to the trial coordinating staff at the LSHTM CTU. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA, NIHR, NHS or the Department of Health.


Conflict of Interest StatementES and AS are the creators of the software package Dr. Neuronowski®, realized as part of a project at the Nencki Institute with funding from the National Centre for Research and Development in Poland. The rights to the software lie with the Nencki Institute that has an agreement with Harpo Ltd., the company commercializing this software. ES and AS are not the owners of this technology nor do they have a direct financial arrangement with Harpo Ltd.The authors state that the correction does not affect the scientific validity of the results.ES: experimental design, data acqusition and analysis, manuscript writing. AD: data acqusition and analysis, manuscript writing. AS: data acqusition and analysis, manuscript writing. TW: guidance on MRI data analysis. AS: subject recruitment. ID: subject recruitment. AO: data acqusition and analysis, manuscript writing.The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


The second and third authors affiliation was incorrectly stated as both the University of York and the University of Sheffield, which requires amendment . This correction does not in any way affect the scientific validity of the results.GP conceived of, and designed, the study in consultation with PT, LE, and EM. GP conducted the study and analyzed the data with assistance and contributions from PT. GP drafted the manuscript with contributions from PT, LE, and EM. All authors read and approved the final manuscript.This research was supported by the Economic and Social Research Council [grant number ES-J500215-1] awarded to GP whilst at the University of Sheffield.The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


The following information is missing from the Funding statement: This work was also supported by an NSF award (MCB-1051350) to MCY.The complete, correct Funding statement is as follows: This work was supported by a Scientist Development grant (0830279N) from the American Heart Association and an NSF award (MCB-1051350) to MCY. The publication costs of this article were supported by the Julian Park Fund, College of Arts and Sciences, University at Buffalo. The funders had no role in study design, data collection, data interpretation, or the decision to prepare and publish of the manuscript.


Authors who received the funding were CE and LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.There are errors in the Funding section. The correct funding information is as follows: The 2015 data collection was supported by the SeaWorld and Busch Gardens Conservation Fund (


There is an error in the Financial Disclosure (FD) statement for this article. Please refer to the correct FD statement below:http://www.cdc.gov/cancer/npcr/) to the Puerto Rico Central Cancer Registry (PRCCR), by the University of Puerto Rico Comprehensive Cancer Center and by the Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico. The ideas and opinions expressed herein are those of the authors, and endorsement by the funders is not intended nor should it be inferred. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.This work is supported by federal funds from the National Program of Cancer Registries (NPCR Award Number 5U58-DP 003863-02; URL:


In the abstract, the name of cell line appears as SCH7072. The name of this cell line should read as SCH07072.The Funding statement should be corrected to read as follows: This study was supported, in part, by a grant from the Agenda (No. PJ0102012014) from the Rural Development Administration (RDA) of Korea and the Korea Institute of Ocean Science and Technology project (No. PE99154) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


Sirs,et al. published in June 2014. We are conscious that, since the study was undertaken in 2010, the public health research landscape in the UK has developed considerably. A number of programmes were set up in 2009 which now have strong portfolios of public health research. All parts of the National Institute for Health Research (NIHR) support research in public health to provide significant opportunities for researchers and evidence for practitioners and decision-makers . Public health research is particularly funded by the NIHR through the Public Health Research programme, focusing on interventions outside of health care, and the School for Public Health Research. The Health Technology Assessment programme evaluates NHS interventions, while Programme Grants for Applied Research supports NHS research delivering findings with early practical application. While the remit varies by programme, covering England or the UK, the application of research findings could extend across Europe. Research for public health is also supported by other Department of Health funding schemes, such as the Policy Research Programme and other funding bodies; for example, a recent option for early-phase intervention research is the Medical Research Council's Public Health Intervention Development scheme. NIHR outputs are captured in a suite of five peer-reviewed, open access journals for anyone to use . We welcome contributions to identify research needs, deliver research to answer key questions and bring new evidence back into practice to strengthen public health research in the UK for the future.We read with interest ‘Public health research in the UK: a report with a European perspective’ by McCarthy


A population-based cancer registry has been used for the planning and evaluation of cancer control activities based on administration and the care of individual cancer patients by those in the medical profession. The Japanese Breast Cancer Society (JBCS) registry was started in 1975. In 2004, the registry system was moved to a new system using web registration with the cooperation of the Non-Profit Organization Japan Clinical Research Support Unit and Public Health Research Foundation . Comprehensive individual patient data were recorded according to the Unio Internationalis Contra Cancrum (UICC) TNM classification . Annual We herein report the results of a 5-year prognostic analysis of cases registered in 2005


In the Funding section, the grant number 61370109 was omitted from the National Science Foundation of China. Please view the complete, correct Funding statement here.This work was supported by the National Science Foundation of China under Grant Nos. 61272339 & 61370109, the Natural Science Foundation of Hubei Province under Grant No. 2012FFB04204, and the Key Project of Anhui Educational Committee, under Grant No. KJ2012A005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The Academic Editor field does not appear on this article. The Academic Editor is Stuart Humphries, University of Lincoln, United Kingdom. The publisher apologizes for the error.


The affiliation for the fourth author is incorrect. Ruoling Chen is not affiliated with #3 but with #4 Centre for Health and Social Care Improvement (CHSCI), University of Wolverhampton, Wolverhampton, United Kingdom.


A funder was omitted from the Financial Disclosure of the published article. The complete, correct, Financial Disclosure is: This work was partially supported by the Scientific and Technological Research Council of Turkey (TUBITAK) Project No: 113M237 and Bogazici University Scientific Research Fund (BAP) Project No: 9360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The publisher apologizes for the error. The correct funding information is as follows: GC was supported by the European Union European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu, by Estonian Personal grants PUT-766 and Estonian Institutional Research grants IUT24-1.The Acknowledgement section is missing from the text. The Acknowledgements are as follows: We thank both of the anonymous reviewers for their constructive criticism. Computational analyses were carried out at the High Performance Computing Center (HPC), University of Tartu and the Core Computing Unit of the Estonian Biocentre.


As a follow up to OpenCon 2014, International Federation of Medical Students’ Associations (IFMSA) students organized a 3 day workshop Open Access, Open Education Resources and Open Data in Kampala from 15-18 December 2014. One of the aims of the workshop was to engage the Open Access movement in Uganda which encompasses the scientific community, librarians, academia, researchers and students. The IFMSA students held the workshop with the support of: Consortium for Uganda University Libraries (CUUL), The Right to Research Coalition, Electronic Information for Libraries (EIFL), Makerere University, International Health Sciences University (IHSU), Pan African Medical Journal (PAMJ) and the Centre for Health Human Rights and Development (CEHURD). All these organizations are based or have offices in Kampala. The event culminated in a meeting with the Science and Technology Committee of Parliament of Uganda in order to receive the support of the Ugandan Members of Parliament and to make a concrete change for Open Access in the country. Librarians, academia and researchers in Uganda have shown a continuous and resolute interest in the Open Access movement. Open Access journal publishing initiatives and support to Open Access repositories can prove it. The Makerere University Library, for example, was the first library in Uganda to set up an institutional repository called the Uganda Scholarly Digital Library (USDL). Launched as a science repository but later changed to cover other disciplines, USDL has a total of 1,600 full text articles, reports, posters, and other scholarly materials [Next Generation of Medical Researchers workshops’. The previous two were pre- General Assembly workshops focusing on Research Integrity. To follow up with those pre-GAs, more workshops have been planned for the regional meeting as well and As Africa was the first region to host the meeting, we decided to focus on: a core part of research data; on educational resources fundamental for students and researchers; and, on research outputs and how to share them. Our main aim is to build capacities to launch and sustain Open Access,  and OD (Open Data) activities, projects and policies in the region, especially at national and local level. For this reason we decided to create a network in Uganda with local Universities and personalities based in the capital of Uganda, Kampala. The 10th African Regional Meeting was held in Kampala, Uganda under the theme Human Resources for Health: A foundation for Universal Health Coverage and was organized by the Federation of Uganda Medical Students Association (FUMSA). We received support from: Consortium for Uganda University Libraries (CUUL), The Right to Research Coalition [The IFMSA participated in the OpenCon 2014 from 15-17 November 2014 in Washington DC, and the representatives  came back with lot of enthusiasm and a willingness to share their knowledge and new ideas with the medical students. In order to follow up with the OpenCon 2014 a pre Africa Regional Meeting Open Access, Open Education Resources and Open Data was held in Kampala, Uganda from 15-18 December 2014. This pre- ARM workshop was organized within the series of ‘The students had the chance to meet and be trained by University Librarians from the International Health Sciences University and Makerere University Business School. The librarians are: Florence Mirembe who is also the Chairperson of the Consortium of Uganda University Libraries (CUUL) which promotes access to e-resources to support education and research within universities and other research institutions, and she is also the EIFL (Electronic Information for Libraries) country coordinator; Alison Kinengyere who is also the outgoing president of Association of African Health Librarians-Uganda Chapter and Hassan Segooba who is a librarian at the Makerere University Business School Library. In this way medical students can join their effort to promote Open Access. The participants also had the chance to get also the perspective of a medical journal editor thanks to the participation of Allan Mwesiga from the Editorial Office of the Pan African Medical Journal who shared the experience and achievements of an African Medical Journal as an Open Access journal. Under the guidance of Nsereko Ibrahim from the Centre for Health Human Rights and Development (CEHURD) participants learned more on promoting Open Access and on how to organize initiatives in Uganda, but also in other Universities with A case for CC licensing opportunities in Uganda.Through this event facilitated by Meggie, Agostinho and Mohamed, the students developed critical skills as well as advocacy and practical skills and had the opportunity to share their backgrounds, their project, how they have been involved in OA, OER and OD and analyse examples of successful projects with a view to planning on how to improve them or how to adapt them to their backgrounds. They are now looking forward to spreading awareness about Open Access. The event culminated in a meeting with the Science and Technology Committee of Parliament of Uganda, where the workshop participants presented a statement. There will be a follow up on this with the Ugandan Members of Parliament in order to receive their support and to make a concrete change in the country.


The following funder is missing from the Funding section: Deutsche Herzstiftung. The correct funding information is as follows: This work was funded by the Deutsche Forschungsgemeinschaft (DFG) and the Deutsche Herzstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The original Supporting Information files were published in error. The files were removed from the HTML and PDF versions of this article on March 11, 2016. The publisher apologizes for the error.


The following information is missing from the Funding section: This work was supported by the European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH (project No. 613877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: The authors acknowledge the financial support of the Bankwest Curtin Economics Centre and the Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC), established and supported under the Australian Government's Cooperative Research Centres Program. The authors acknowledge the financial support of Curtin University to Melissa Scott through the Australian Postgraduate Award Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.There is information missing from the Acknowledgments. The Acknowledgments should read: Our sincere thanks go to Wilson Waters, the software engineer from Alintech. The online version of the Q sort would not have been possible without your development and innovation. We are grateful to all the participants, their families and businesses who participated. A special mention goes to EDGE Employment Solutions, EPIC Employment Service, Barkuma’s Personnel Employment in South Australia, Autism Spectrum Australia and AIM Employment of the Autism Association of Western Australia, for their assistance with participant recruitment in this study.The authors acknowledge the financial support of the Bankwest Curtin Economics Centre and the Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC), established and supported under the Australian Government's Cooperative Research Centres Program.


The meteorological data was used to assess the PV, wind and hydropower system potentials on the islands. Furthermore, the reconnaissance study for hydro-potentials were conducted through topographic maps in order to determine the potential sites suitable for development of run-of-river hydropower generation. The stream data was collected for 14 islands in the South China Sea with a total of 51 investigated sites. The data from this study are related to the research article  Specifications TableValue of the data•The data describes the meteorological and topographical conditions of the resort islands in the South China Sea•This data contains key information for renewable energy assessments for resort islands in the South China Sea.•This data can be used for other research fields that involve the usage of solar radiation, wind speed, rainfall and evaporation data.•The topographic map data is valuable for determining the potential run-of-river hydropower sites in many resort islands in the South China Sea.1The data consists of meteorological and topographical data for resorts islands in the South China Sea.The selected resort islands location is shown in 2The meteorological data for the resort islands was obtained from the Malaysia Meteorological Department (MMS) and also the NASA Prediction of Worldwide Energy Resource (NASA POWER) database. If there is no meteorological station on the island, the meteorological data was collected from the nearest available meteorological station. The nearest station information׳s also included in this article The topographic map obtained from Department of Survey and Mapping Malaysia (DSMM) was used for the study. The map is classified and must be used within the DSMM map library. The characteristic of the map used for this research is a Malaysian topography map (Series L 7030) with 1:50,000 scales and a contour interval of 20 m. The physiographic characteristics were extracted from the map for prediction of run-of-river hydropower potential sites. The important information extracted and analyzed from the map were: the name of streams and catchment areas, latitude and longitude of the location, lowest and highest elevation, the terrain and river profile, possible intake, diversion to fore bay, power house elevation, and the estimation of available head and catchment areas.Three key factors were considered for selecting catchment areas from a topographic map that were suitable for harnessing hydropower. The key factors were energy demand, accessibility and river profile. The catchment areas topographies were studied for determining the appropriate elevation for head and stream diversion. The river profile, which is the river׳s tributaries and gradient, was considered for finding the availability of water resources and river flow. Based on the hydropower manual and guides


In the Funding section, the first grant number from the Japan Society for the Promotion of Science is listed incorrectly. The correct number for the first grant is: Grant-in-Aid for Young Scientist (B) 25780404.


There are errors in the Funding section. The correct funding information is as follows: This project was supported by the President's Emergency Program For AIDS Relief and the NIH Office of AIDS Research, through NIH Grant Number U01 AI100015 to author SR at Boston University, from the National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There is an error in the “Acknowledgements” and “Financial Disclosure” statements. Please refer to the correct statements below:Acknowledgments:We thank the more than 500 lay botanists who contributed to the Japanese Red Data Book project directed by the Japanese Society for Plant Systematics. We also thank Kazuo Somiya, of the Ministry of the Environment of Japan, and Yasuhiro Ibaragi, Masato Nagatsu, and Kaori Sato, of the Japan Wildlife Research Center, for their help and encouragement during the project. This work was supported by theMinistry of the Environment of Japan and the Japanese Society for Plant Systematics.Financial Disclosure:This work was supported in part by the Environment Research and Technology Development fund (S9-1) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The Funding Statement is missing an acknowledgment to the Advanced Molecular Detection Initiative at the CDC. The correct Funding Statement is provided here:ET is supported by an American Society for Microbiology (ASM) and Centers for Disease Control and Prevention Postdoctoral Fellowship. We acknowledge support from the Advanced Molecular Detection Initiative at the CDC, the Atlanta Research and Education Foundation, Atlanta, GA, and the CDC Antimicrobial Resistance Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The following information is missing from the Funding section: Dr. Tarr is also supported by the National Institutes of Health [5P30 DK052574 (DDRCC)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: This work and survey components were supported by the High Impact Research Grant (UM.C/625/1/HIR/162) from the Ministry of Higher Education  and University Malaya Research Grant (RP004A-SUS). Studies design and data collections were done by the academic staff at the Institute of Biological Science, University Malaya, Kuala Lumpur, Malaysia. Analyses undertaken and the decision to prepare and publish this manuscript were made by Institute staff in conjunction with the Chemistry Department of University Malaya.


There are errors in the Funding section. The correct funding information is as follows:This work was supported by the China 973 Project (Grant No. 2009CB941701) and National Natural Science Foundation of China (Grant No. 31071316) to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There are errors in the Funding section. The correct funding information is as follows: This study was supported by the Institute for Clinical Evaluative Sciences (ICES) and Public Health Ontario (PHO), which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, PHO, or the Ontario MOHLTC is intended or should be inferred.The images for figures Figs There was information omitted from the Acknowledgements. The complete Acknowledgements is as follows: These datasets were linked using unique encoded identifiers and analyzed at ICES. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed herein are those of the author, and not necessarily those of CIHI. The authors wish to acknowledge the assistance of Danijela Draganic, Steven Janovsky and Lennon Li, Public Health Ontario, for assistance with preparation of figures for publication.


UK military personnel injured overseas are repatriated to the Royal Centre for Defence Medicine (RCDM) based at the Queen Elizabeth Hospital Birmingham (QEHB) in Birmingham UK. We report the demographics and outcomes of military patients treated on the ICU at RCDM using data from the Intensive Care National Audit and Research Centre over a 6.5-year period.Data on 570 admissions of 527 patients to the ICU at RCDM/ QEHB were analysed by ICNARC using standard methodology.Some physiology and CCMDS data were missing for 175 patients. Age, sex and mortality are described in Table The data on resource utilisation for this group of patients may inform planning of critical care support for military operations overseas.


The contents of this manuscript are the responsibility of IAVI and co-authors and do not necessarily reflect the views of USAID or the United States Government.There are errors in the Funding section. The correct funding statement is as follows: This work was made possible by generous support from many donors including; The training Health Researchers into Vocational Excellence in East Africa Project (THRiVE), Grant Number 087540 of Welcome trust, UK, and the Canada-Africa Prevention Trials Network (CAPTN) Grant Number 1063357–001. It was also funded in part by IAVI and made possible by the generous support of the United States Agency for International Development (USAID) and other donors. The full list of IAVI donors is available at


There is an error in the Funding section. The correct funding information is as follows: The study was funded by National Natural Science Foundation of China (No. 51378226). It had an important role in study design, data collection and analysis.


There are errors in the Competing Interests section. The correct competing interests information is as follows: This study was supported in part by the Agency for Science Technology and Research (A*STAR) Singapore. This does not alter our adherence to PLOS ONE policies on sharing data and materials.


Mental Health and Deafness. At the World Congress of Mental Health and Deafness held in 2014, a prize for the best poster was established in his name.Nick Kitson, who died suddenly at the age of 64 while on holiday on 24 February 2014, was a pioneer and national expert in the psychiatric disorders of deaf people. He was the Founding Chair of the British Society for Mental Health and Deafness and the longest serving president of the European Society for Mental Health and Deafness (1990-1997), remaining honorary member and honorary vice president of each, respectively. He was clinical advisor to the Towards Equity and Access Implementation Panel  in 2006/2007 and ‘responsible owner’ of a National Deaf Mental Health Commissioning Project. He remained a trustee of and medical advisor to the Sign health charity and awarded the title of Pioneer. He was joint editor of the standard introductory textbook Nick completed his medical training at St Bartholomew's Hospital in 1975. He was appointed consultant psychiatrist at Springfield University Hospital and honorary senior lecturer at St George's Medical School in 1984. He was clinical director for the Specialist Mental Health Services for the Deaf Community at Springfield and medical director of Pathfinder NHS Trust from 1994 to 1998. When he became responsible for the psychiatric care of people with deafness, his health authority gave him 9 months to learn sign language. He visited psychiatric units for deaf people in America and realised the importance of employing deaf people fluent in sign language. At the time he wrote about sign language: ‘It is a very sophisticated language capable of expressing everything you can say in English.’ The service for deaf people that he led and developed for 18 years, with his wife Karen, covered the southern half and then a third of England. He became a Member of the Royal College of Psychiatrists in 1980 and was elected a Fellow in 1996.While working as a consultant, he trained in short-term dynamic therapy in 1984 and group analytic psychotherapy in 1989. He became an associate member of the London Centre for Psychotherapy (British Psychotherapy Foundation) in 1989 and a Full Member in 1996, supervising short-term dynamic psychotherapy at the Tavistock and latterly at the London Centre for Psychotherapy. Psychotherapy was always an integral part of his clinical practice. He provided strong support for Jane Douglas, the first profoundly deaf person to train as a psychoanalytic psychotherapist.Knowing the West Country well, Nick left London and moved to Cornwall in 2002. He initially worked as a community and in-patient psychiatrist covering the St Austell area but, wishing to reduce his workload owing to ill health, he became part-time consultant to the psychiatric intensive care unit (PICU). The service was awarded the National PICU of the Year in 2005. Formally retiring in 2009, he continued as his own locum for the PICU, regularly sailing and taking trips abroad with Karen and his family.Nick was a hugely respected consultant psychiatrist. His colleagues frequently sought his advice in difficult circumstances, and the advice he gave was wise and supportive. He was down-to-earth and sensible; he never pretended he knew the answer when he did not, but his advice was even sounder in these circumstances. He continued to use his therapeutic skills after retirement and remained enthusiastic and determined to help the most challenging and difficult patients.He will be sorely missed by his colleagues but his wise leadership will continue to be influential. He is survived by Karen, his two daughters and his grandchildren.


She is with the European Programme for Intervention Epidemiology Training (EPIET) at the European Centre for Disease Prevention and Control, Stockholm, Sweden. The article has been corrected online (


The role of medical schools is in a process of change. The World Health Organization has declared that they can no longer be ivory towers whose primary focus is the production of specialist physicians and cutting edge laboratory research. They must also be socially accountable and direct their activities towards meeting the priority health concerns of the areas they serve. The agenda must be set in partnership with stakeholders including governments, health care organisations and the public.The concept of social accountability has particular resonance for the Bar Ilan Faculty of Medicine in the Galilee, Israel’s newest medical school, which was established with a purpose of reducing health inequities in the Region. As a way of exploring and understanding the issues, discussions were held with international experts in the field who visited the Galilee. A symposium involving representatives from other medical schools in Israel was also held to extend the discourse. Deliberations that took place are reported here.The meaning of social accountability was discussed, and how it could be achieved. Three forms of action were the principal foci – augmentation of the medical curriculum, direct action through community engagement and political advocacy. A platform was set for taking the social accountability agenda forward, with the hope that it will impact on health inequalities in Israel and contribute to discussions elsewhere. Closing the Gap in a Generation[, it reported that many of the differences in health between and within countries stem from the social environment where people are born, live and age. The Commission recommended a two-pronged approach to redressing health inequities – improving people’s daily living conditions and tackling inequitable distribution of power, money and resources.In 2008 the World Health Organisation (WHO) published a report written by its Commission on Social Determinants of Health. Entitled eneration, it repoAlthough medical professionals can only have a limited role in implementing these recommendations, they nonetheless have a clear responsibility to address health inequities in the course of their work. This challenge was taken up by pioneering medical schools, many of whom were new schools. They were established with a paradigm shift - embedding improvement in community health with innovations in health professional education, with delivery and health policy at the core of their business. These schools engaged initially in establishing a network of community orientated medical schools, of which Ben Gurion University of the Negev was one, and evolved into an official relationship with the WHO as The NetWork.The concept was taken further at a groundbreaking international meeting in South Africa in 2009 bringing together representatives of 130 organisations and individual experts from around the world with responsibility for health education, professional regulation and policy making to produce a Global Consensus for Social Accountability of Medical Schools (GCSA 2010),5.Closing the gap in a generation[Global Consensus[eneration and the onsensus have speonsensus.This discussion document reflects some of the ideas and discussion that took place. Issues that were explored included: what is meant by social accountability; how it can be achieved; the role of medical education, direct action and advocacy; and how we can measure success over time.The World Health Organisation defines social accountability as the obligation for medical schools to direct their activities towards meeting priority health concerns that are agreed in partnership with stakeholders nationally and locally. In many ways it is the next stage in the service, research and education revolution started several decades ago by the Community Oriented Primary Care movement, developsocially responsible when they teach about health inequalities and the impact that social determinants have on health. Social responsiveness goes a step further as it involves taking action in response to societal or local community health needs. Abstracts submitted to the symposium  originally implying shared responsibility for proper social and moral conduct in the community, but used in more recent centuries to connote mutual responsibility for social welfare.“Tiqqun ’olam” was translated in the title of Jonathan Sacks’ book as “To heal a fractured world – the ethics of responsibility” .None of the authors have declared competing interests.All the authors made substantial contributions to the discussions underpinning this paper. The manuscript was drafted by MCJR and the remaining authors contributed critical revisions and gave final approval of the version submitted to IJHPR. They all agree to be accountable for all aspects of the work and in ensuring that questions related to the accuracy or integrity of any part are appropriately investigated and resolved. All authors read and approved the final manuscript.Professor Mary Rudolf is the lead for Public Health at the Bar Ilan University Faculty of Medicine in the Galilee since 2012, and visiting Professor of Child Health at the University of Leeds, UK. Areas of special interest include childhood obesity, paediatric education and social accountability of medical schools. Professor Shmuel Reis is a Family Physician in a rural health center, head of the Faculty Development Unit and the Clinical Skills Course director of the Bar Ilan University Faculty of Medicine in the Galilee. Professor Trevor Gibbs is an Independent and WHO Consultant in Medical Education, Primary Care and Adolescent Health. He also holds the position of Development officer for AMEE. His main areas of interest are in International medical curricula, Competency-Based Education, Social Accountability and Nutrition and Health. Professor Deborah Murdoch-Eaton is Dean of Medical Education, at The Medical School, University of Sheffield, UK. Her academic interests focus on Global Health, developing students' potential and individuality, embedding Social Accountability within medical education, and role of feedback in the development of learning skills. Professor David Stone is Emeritus Professor of Paediatric Epidemiology at the University of Glasgow, UK. Previous positions included Senior Lecturer in Epidemiology at Ben Gurion University of the Negev, Israel and Senior Medical Advisor to the Scottish Government’s Chief Medical Officer. Dr Michael Grady is an expert adviser to WHO and special adviser to the UK House of Commons Community and Local Government Select Committee. He advises Local authorities and municipalities nationally and internationally on implementation on action on the social determinants of health. Dr Anita Berlin is an inner London General Practitioner and a senior lecturer in primary care at University College London. She is curriculum lead for the new Social Determinants of Health Module and for Patient and Public Participation. Prof Mitch Blair is Consultant Paediatrician and Reader in Child Public Health Imperial College London and Northwick Park Hospital. He is undergraduate paediatrics course lead for Imperial medical students and has a strong interest in teaching Child Rights and Health Inequalities. Dr Jumanah Essa-Hadad has a PhD in Public Health from the University of Haifa. Research interests include web-based health education and health of minority groups and disadvantaged populations. Her background includes working with NGO's and civil society organizations at the grassroots level to promote public health programs. Ms Sivan Shohat holds a Master's degree in Sociology specializing in health care policy and the role healthcare organizations have in reducing health and healthcare disparities. Professor Michael Weingarten is Associate Dean for Medical Education at the Bar Ilan University Faculty of Medicine in the Galilee. A family practitioner by background, he has a special interest in medical ethics.


The following information is missing from the Funding section: grant number LD13046 from the Ministry of Education, Youth and Sports of the Czech Republic and the acknowledgment of funding from the EU COST action ES1103.www.daad.de) providing travel grants for VR and MS, from the Ministry of Education, Youth and Sports of the Czech Republic , from the Grant Agency of the Czech Republic , and from the EU COST action ES1103, which provided funding for the author (AC) to attend a workshop.The complete, correct Funding statement is: This project was funded by a grant from the German Academic Exchange Service (DAAD,


In the Materials and Methods, an Institutional Animal Care And Use Committee (IACUC) protocol number was incorrectly cited. The authors wish to correct the record by reporting that there was no University of Texas at Arlington (UTA) IACUC protocol number for this research because the research was not conducted at UTA, with the exception of the dissection of the python, which took place without UTA IACUC approval. The corrected text and additional details and clarification are provided below for the tissue sample from the Burmese python, as well as the samples from two birds, the Gunnison Sage-grouse and Clark's Nutcracker.Python molurus bivittatus was obtained by the UTA Amphibian and Reptile Diversity Research Center from a commercial breeder in August of 2007, immediately euthanized using a chloretone solution, and tissues preserved following animal protocols outlined in the Guidelines for Use of Live Amphibians and Reptiles in Field Research, established jointly by the American Society for Ichthyologists and Herpetologists, Herpetologist's League, and the Society for the Study of Amphibians and Reptiles . Liver tissue from the python (snap-frozen in liquid nitrogen and stored at -80°C) was used as a source for genomic DNA."All specimens used in this study were obtained from collaborators and not collected by the authors. There was no University of Texas at Arlington (UTA) IACUC protocol number for this research as the research was not conducted at UTA, with the exception of the dissection of the python, which took place without UTA IACUC approval. A single The Gunnison Sage-grouse was trapped and blood was sampled by personnel from the Colorado Division of Wildlife. The trapping method and blood sampling was approved through their Animal Care and Use Committee; however, at the time, no permit was required to trap and sample the bird (the bird was still being actively hunted at the time when the sample was taken). There was no number issued in terms of an IACUC.The tissue from the Clark's Nutcracker was provided from a dead carcass of a bird that died of natural causes in the lab of Russell Balda at Northern Arizona University after more than a decade as an experimental bird for memory studies. The bird was originally caught in Logan Canyon in the 1990s by Stephen Vander Wall (University of Nevada Reno), under the IACUC protocol number 00–006 Russell Benford, Ph.D., Department of Biological Sciences, Northern Arizona University.


In the Funding section, the grant number from the funder the National Natural Science Foundation of China is listed incorrectly. The correct grant number is: 31072055. The complete, correct funding information is as follows: This work was financially supported by the National Natural Science Foundation of China (Project no. 31072055) and The Ministry of Science and Technology of China (Project no. 2011BAD26B03-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


There is an error in the Funding section of the published article. The Funding section should read: This study was supported by a grant of the Jeju National University Research Fund (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


In the Acknowledgements section, the following information is missing: All data in this paper were provided by the TEAM Network, a partnership between Conservation International, The Missouri Botanical Garden, The Smithsonian Institution and The Wildlife Conservation Society.


The Acknowledgments section is incorrectly reported. The correct Acknowledgments section should read: We want to thank Dr. Rabie Mohammed Algdgad and Dr. Ahmed Bazza, Tripoli Medical Center for the contribution in collecting of data, and Prof. Michael Eddleston, Edinburgh, Scotland for his invaluable input and critical review of the manuscript. Study expenses were supported from the regular operation budgets of the MSF Kenya and Libyan missions as well as Oslo University Hospital, but had no role in the writing of the report as such.